chartexchange

WVE
Wave Life Sciences Ltd.
stockNASDAQ

Market OpenNov 19, 2026 3:33:47 PM EST
2.69USD-2.708%(-0.08)1,287,320
Pre-marketNov 19, 2026 9:13:30 AM EST
2.8254USD+2.000%(+0.0554)
2.6900Bid2.7000Ask0.0100Spread
Loading…
Loading…
530.66M
Healthcare
Biotechnology
CEO
Paul Bolno
HQ
Singapore, 12 00 Marina One East Tower, Singapore
Previous Close
$2.77
Beta
1.52
52-Week High
$21.73 2025-12-09
52-Week Low
$2.75 2026-11-18
SMA 50
$3.61
SMA 200
$6.76
Avg. Vol 10D
2.70M
Avg. Vol 30D
2.88M
Avg. Vol 90D
3.06M
Relative Vol
0.44
197.23M
165.32M
20,649,846
0.2800%
2,200,000
15,689
WVE Profile

wave life sciences ltd. (nasdaq: wve) is utilizing its innovative and proprietary synthetic chemistry drug development platform to design, develop and commercialize stereopure nucleic acid therapeutics that precisely target the underlying cause of rare genetic diseases, delivering new treatment options for patients. given the unique versatility of its chemistry platform, wave's pipeline spans multiple oligonucleotide modalities including antisense, exon-skipping and single-stranded rnai.

WVE Performance
PeriodPriceDateChangeBeta
1W3.162026-11-12-14.72%3.962
1M3.172026-10-19-15.12%2.353
3M5.422026-08-19-50.31%1.677
6M6.142026-05-19-56.18%1.455
1Y6.882025-11-19-60.89%1.523
2Y14.212024-11-19-81.06%—
5Y4.312021-11-19-37.57%1.409
WVE Stock Summary

Wave Life Sciences Ltd. (NASDAQ:WVE) stock price today is $2.69, and today's volume is 1,279,952. WVE is down 2.866% today. The 30 day average volume is 2.88M. WVE market cap is $530.66M with 197.23M shares outstanding.